A peer-mentoring program to help Black and Latinx adolescents with type 1 diabetes use continuous glucose monitors.
Glu-COACH: a peer-mentoring intervention to reduce disparities in CGM use in adolescents with type 1 diabetes
This study is all about helping Black and Latinx teens with type 1 diabetes use continuous glucose monitors better by pairing them with supportive peers who understand their unique challenges.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10894172 on NIH RePORTER |
What this research studies
This research focuses on improving the use of continuous glucose monitoring (CGM) devices among Black and Latinx adolescents with type 1 diabetes, who often face challenges in managing their condition. The Glu-COACH program will utilize peer mentoring to provide support and encouragement, addressing both cultural and developmental factors that affect diabetes management. By engaging stakeholders, including patients and parents, the program will be tailored to meet the specific needs of these communities. The effectiveness of this intervention will be evaluated to determine its impact on CGM uptake and maintenance.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black and Latinx adolescents aged 12-18 who have been diagnosed with type 1 diabetes.
Not a fit: Patients who do not have type 1 diabetes or are outside the adolescent age range may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diabetes management and health outcomes for Black and Latinx adolescents with type 1 diabetes.
How similar studies have performed: Previous research has shown that peer mentoring can effectively improve health outcomes in other chronic illness models, suggesting potential success for this approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Weinzimer, Stuart Alan — Yale University
- Study coordinator: Weinzimer, Stuart Alan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.